COVID-19-associated anemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 10: | Line 10: | ||
==Overview== | ==Overview== | ||
[[COVID-19|Coronavirus disease 2019 (COVID-19)]] is caused by a novel [[coronavirus]] called [[SARS-CoV-2]], which caused a respiratory illness [[outbreak]] that was first detected in Wuhan, China. Anemia in general is defined as a hemoglobin level of less than 13 | [[COVID-19|Coronavirus disease 2019 (COVID-19)]] is caused by a novel [[coronavirus]] called [[SARS-CoV-2]], which caused a respiratory illness [[outbreak]] that was first detected in Wuhan, China. [[Anemia]] in general is defined as a [[hemoglobin]] level of less than 13 gm/dL in men and less than 12 gm/dL in women by the [[World Health Organization|World Health Organization (WHO)]]. Although [[anemia]] is not a common finding in patients with [[COVID-19]] infection, decrease in [[hemoglobin]] in patients with severe [[COVID-19]] infection has been reported. The [[pathophysiology]] of decrease in [[hemoglobin]] in patients with [[COVID-19]] infection are hypothetically affected [[erythropoiesis]] due to [[inflammation]] during [[COVID-19]] infection which leads to decrease in [[hemoglobin]]. | ||
==Historical Perspective== | ==Historical Perspective== | ||
| Line 24: | Line 24: | ||
* The following is the classification of [[anemia]] in general by red blood cell size with [[Mean corpuscular volume|mean corpuscular volume (MCV)]]: | * The following is the classification of [[anemia]] in general by red blood cell size with [[Mean corpuscular volume|mean corpuscular volume (MCV)]]: | ||
**[[Macrocytic anemia]] (MCV>100) | **[[Macrocytic anemia]] ([[Mean corpuscular volume|MCV]]>100) | ||
**[[Normocytic anemia]] (80<MCV<100) | **[[Normocytic anemia]] (80<[[Mean corpuscular volume|MCV]]<100) | ||
*** High [[reticulocyte]] count | *** High [[reticulocyte]] count | ||
*** Low [[reticulocyte]] count | *** Low [[reticulocyte]] count | ||
| Line 31: | Line 31: | ||
==Pathophysiology== | ==Pathophysiology== | ||
The [[pathophysiology]] of decrease in hemoglobin and rarity of anemia in patients with [[COVID-19]] infection are as the followings:<ref name="pmid32495027">{{cite journal| author=Liu X, Zhang R, He G| title=Hematological findings in coronavirus disease 2019: indications of progression of disease. | journal=Ann Hematol | year= 2020 | volume= | issue= | pages= | pmid=32495027 | doi=10.1007/s00277-020-04103-5 | pmc=7266734 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32495027 }} </ref> | The [[pathophysiology]] of decrease in [[hemoglobin]] and rarity of [[anemia]] in patients with [[COVID-19]] infection are as the followings:<ref name="pmid32495027">{{cite journal| author=Liu X, Zhang R, He G| title=Hematological findings in coronavirus disease 2019: indications of progression of disease. | journal=Ann Hematol | year= 2020 | volume= | issue= | pages= | pmid=32495027 | doi=10.1007/s00277-020-04103-5 | pmc=7266734 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32495027 }} </ref> | ||
*[[Erythropoiesis]] may be affected by [[inflammation]] during [[COVID-19]] infection which leads to decrease in [[hemoglobin]].<ref name="pmid32495027" /> | *[[Erythropoiesis]] may be affected by [[inflammation]] during [[COVID-19]] infection which leads to decrease in [[hemoglobin]].<ref name="pmid32495027" /> | ||
| Line 41: | Line 41: | ||
==Causes== | ==Causes== | ||
[[COVID-19|Coronavirus disease 2019 (COVID-19)]] caused by a novel [[coronavirus]] called [[SARS-CoV-2]] is the cause of [[COVID-19]]-associated-[[anemia]]. | |||
* [[COVID-19|Coronavirus disease 2019 (COVID-19)]] caused by a novel [[coronavirus]] called [[SARS-CoV-2]] is the cause of [[COVID-19]]-associated-[[anemia]]. | |||
==Differentiating COVID-19-associated Anemia from other Diseases== | ==Differentiating COVID-19-associated Anemia from other Diseases== | ||
| Line 49: | Line 50: | ||
*[[Thalassemia]] | *[[Thalassemia]] | ||
*[[Sideroblastic anemia]] | *[[Sideroblastic anemia]] | ||
*Anemia of inflammation | *[[Anemia]] of [[inflammation]] | ||
*[[Aplastic anemia]] | *[[Aplastic anemia]] | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[Liver]] disease | *[[Liver]] disease | ||
*[[Kidney|Renal]] disease | *[[Kidney|Renal]] disease | ||
*Reticulocytosis | *[[Reticulocytosis]] | ||
*[[Thyroid]] disease | *[[Thyroid]] disease | ||
*Vitamin [[Vitamin B12 | *[[Vitamin]] [[Vitamin B12|B12]] and [[folate deficiency]] | ||
*[[Chemotherapy]] | *[[Chemotherapy]] | ||
*[[Myelodysplastic syndrome]] | *[[Myelodysplastic syndrome]] | ||
Revision as of 11:52, 16 July 2020
For COVID-19 frequently asked inpatient questions, click here
For COVID-19 frequently asked outpatient questions, click here
|
COVID-19 Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
COVID-19-associated anemia On the Web |
|
American Roentgen Ray Society Images of COVID-19-associated anemia |
|
Risk calculators and risk factors for COVID-19-associated anemia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Synonyms and keywords: Hemoglobin changes in COVID 19, anemia in COVID 19, effects on erythropoiesis in COVID 19
Overview
Coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus called SARS-CoV-2, which caused a respiratory illness outbreak that was first detected in Wuhan, China. Anemia in general is defined as a hemoglobin level of less than 13 gm/dL in men and less than 12 gm/dL in women by the World Health Organization (WHO). Although anemia is not a common finding in patients with COVID-19 infection, decrease in hemoglobin in patients with severe COVID-19 infection has been reported. The pathophysiology of decrease in hemoglobin in patients with COVID-19 infection are hypothetically affected erythropoiesis due to inflammation during COVID-19 infection which leads to decrease in hemoglobin.
Historical Perspective
- Coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus called SARS-CoV-2, which caused a respiratory illness outbreak that was first detected in Wuhan, China.[1][2]
- On January 30, 2020, the outbreak was declared a Public Health Emergency of International Concern.
- On March 12, 2020, the COVID-19 outbreak was declared a pandemic by the World Health Organization (WHO).
Classification
- Anemia, in general, is defined as a hemoglobin level of less than 13 g/dL in men and less than 12 g/dL in women by the World Health Organization (WHO).
- The following is the classification of anemia in general by red blood cell size with mean corpuscular volume (MCV):
- Macrocytic anemia (MCV>100)
- Normocytic anemia (80<MCV<100)
- High reticulocyte count
- Low reticulocyte count
- Microcytic anemia (MCV<80)
Pathophysiology
The pathophysiology of decrease in hemoglobin and rarity of anemia in patients with COVID-19 infection are as the followings:[3]
- Erythropoiesis may be affected by inflammation during COVID-19 infection which leads to decrease in hemoglobin.[3]
- Anemia is not a common finding probably due to the compensation of erythrocyte proliferation caused by pneumonia-induced hypoxia and the long life span of erythrocytes.[3]
| COVID-19 Infection | Inflammation | Effects on Erythropoiesis | Decrease in Hemoglobin | ||||||||||||||||||||||||||||||||||
Causes
- Coronavirus disease 2019 (COVID-19) caused by a novel coronavirus called SARS-CoV-2 is the cause of COVID-19-associated-anemia.
Differentiating COVID-19-associated Anemia from other Diseases
Differential diagnosis of anemia in general may include:[4]
- Iron deficiency anemia
- Thalassemia
- Sideroblastic anemia
- Anemia of inflammation
- Aplastic anemia
- Hypothyroidism
- Liver disease
- Renal disease
- Reticulocytosis
- Thyroid disease
- Vitamin B12 and folate deficiency
- Chemotherapy
- Myelodysplastic syndrome
- Acute onset hemolysis or blood loss
Epidemiology and Demographics
- Anemia is a very rare complication of COVID-19.[3]
- There is no new update about COVID-19 associated anemia.
Risk Factors
There is no associated risk factor For COVID-19 associated anemia.
Screening
There is insufficient evidence to recommend routine screening for anemia in COVID-19 infection.
Natural History, Complications, and Prognosis
- Although anemia is not a common finding in patients with COVID-19 infection, but decrease in hemoglobin in patients with severe COVID-19 infection has been reported.[3][5]
- The median hemoglobin is lower in patients with severe COVID-19 (12.8 g/dL) compared to patients with non-severe infection (13.5 g/dL).[5]
- Decrease in hemoglobin is seen more in critically ill patients with severe COVID-19 infection.[5]
Diagnosis
Diagnostic Study of Choice
- The diagnostic study of choice for anemia is compelete blood count (CBC).
- Anemia, in general, is defined as a hemoglobin level of less than 13 g/dL in men and less than 12 g/dL in women by the World Health Organization (WHO).
- The median hemoglobin is lower in patients with severe COVID-19 (12.8 g/dL) compared to patients with non-severe infection (13.5 g/dL).[5]
History and Symptoms
- Although anemia is not a common finding in patients with COVID-19 infection, but decrease in hemoglobin in patients with severe COVID-19 infection has been reported.[3][5]
- The median hemoglobin is lower in patients with severe COVID-19 (12.8 g/dL) compared to patients with non-severe infection (13.5 g/dL).[5]
- Anemia, in general, is defined as a hemoglobin level of less than 13 g/dL in men and less than 12 g/dL in women by the World Health Organization (WHO).
- There is insufficient information about the symptoms of COVID-19-associated-anemia.
- Patients with anemia in general should be asked about:[6]
- Blood loss
- Duration of the anemia
- Any associated features
- Infection
- Cancer
- Comorbidities that cause anemia (such as renal failure, rheumatoid arthritis, and inflammatory bowel disease)
- Past medical history
- Patient’s ethnicity may influence the differential
- Family history
- Drug history (aspirin and NSAIDs)
Physical Examination
- Although anemia is not a common finding in patients with COVID-19 infection, but decrease in hemoglobin in patients with severe COVID-19 infection has been reported.[3][5]
- The median hemoglobin is lower in patients with severe COVID-19 (12.8 g/dL) compared to patients with non-severe infection (13.5 g/dL).[5]
- Anemia, in general, is defined as a hemoglobin level of less than 13 g/dL in men and less than 12 g/dL in women by the World Health Organization (WHO).
- There is insufficient information about the signs found on physical examination of COVID-19-associated-anemia.
- The physical examination in patients with anemia in general may include checking for:[6]
- Pallor of the conjunctiva
- Lymphadenopathy
- Hepatosplenomegaly
- Bone tenderness
- Petechiae
- Ecchymose
Laboratory Findings
- Compelete blood count (CBC):[4][5]
- The median hemoglobin is lower in patients with severe COVID-19 (12.8 g/dL) compared to patients with non-severe infection (13.5 g/dL).
- Peripheral blood smear: Maybe helpful if there is a suspicion of other causes of anemia. However, there is insufficient evidence recommending routine peripheral blood smear in COVID 19 patients.
- Reticulocyte count: May be helpful if there is a suspicion of other causes of anemia.
- Red cell indices: May be helpful if there is a suspicion of other causes of anemia.
Electrocardiogram
There are no ECG findings associated with COVID-19-associated anemia.
X-ray
There are no x-ray findings associated with COVID-19 associated anemia.
Echocardiography or Ultrasound
There are no echocardiography/ultrasound findings associated with COVID-19-associated anemia.
CT scan
There are no CT scan findings associated with COVID-19 associated-anemia.
MRI
There are no MRI findings associated with COVID-19 associated-anemia.
Other Imaging Findings
There are no other imaging findings associated with COVID-19 associated-anemia.
Other Diagnostic Studies
- Bone marrow examination: May be helpful if there is a suspicion of other causes of anemia. However, there is insufficient evidence recommending routine bone marrow examination in COVID-19 patients[4]
- Cytogenetic and molecular tests : May be helpful if there is a suspicion of other causes of anemia. However, there is insufficient evidence recommending routine cytogenetic and molecular in COVID-19 patients.
Treatment
Medical Therapy
Treatment of anemia in general depends on the cause of anemia.[6] No specific treatment has been reported for COVID-19-associated-anemia.
Surgery
Surgery is not a treatment option for patients with COVID-19 associated anemia.
Primary Prevention
There are no established measures for the primary prevention of COVID-19 associated anemia.
Secondary Prevention
Minimal amount of blood should be drawn for blood tests and only clinically necessary tests should be ordered in order to prevent aggregation of COVID-19 associated anemia.[7]
References
- ↑ https://www.cdc.gov/coronavirus/2019-ncov/about/index.html. Missing or empty
|title=(help) - ↑ Lu, Jian; Cui, Jie; Qian, Zhaohui; Wang, Yirong; Zhang, Hong; Duan, Yuange; Wu, Xinkai; Yao, Xinmin; Song, Yuhe; Li, Xiang; Wu, Changcheng; Tang, Xiaolu (2020). "On the origin and continuing evolution of SARS-CoV-2". National Science Review. doi:10.1093/nsr/nwaa036. ISSN 2095-5138.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 Liu X, Zhang R, He G (2020). "Hematological findings in coronavirus disease 2019: indications of progression of disease". Ann Hematol. doi:10.1007/s00277-020-04103-5. PMC 7266734 Check
|pmc=value (help). PMID 32495027 Check|pmid=value (help). - ↑ 4.0 4.1 4.2 Cascio MJ, DeLoughery TG (2017). "Anemia: Evaluation and Diagnostic Tests". Med Clin North Am. 101 (2): 263–284. doi:10.1016/j.mcna.2016.09.003. PMID 28189170.
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX; et al. (2020). "Clinical Characteristics of Coronavirus Disease 2019 in China". N Engl J Med. 382 (18): 1708–1720. doi:10.1056/NEJMoa2002032. PMC 7092819 Check
|pmc=value (help). PMID 32109013 Check|pmid=value (help). - ↑ 6.0 6.1 6.2 Powell DJ, Achebe MO (2016). "Anemia for the Primary Care Physician". Prim Care. 43 (4): 527–542. doi:10.1016/j.pop.2016.07.006. PMID 27866575.
- ↑ Baron DM, Franchini M, Goobie SM, Javidroozi M, Klein AA, Lasocki S; et al. (2020). "Patient blood management during the COVID-19 pandemic: a narrative review". Anaesthesia. doi:10.1111/anae.15095. PMID 32339260 Check
|pmid=value (help).